620. Real-World Insights on HIV Treatment Decision-Making in Federal and Public Healthcare Settings
Jason F. Okulicz(Gilead Sciences (United States)), Tamar Sapir, Ekaterina S Taneva, Jason M Blaylock, Jeffrey Carter(New York City Department of Education), Laura Simone(University of Nebraska Medical Center), Chad Zawitz(John H. Stroger, Jr. Hospital of Cook County)
Cited by 0
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176
Effect of HIV infection and antiretroviral therapy on immune cellular functions
|JCI Insight|2019|114
Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure
|Clinical Infectious Diseases|2019|110